Safety, Tolerability and Pharmacokinetics of Quisinostat, a Histone Deacetylase Inhibitor, in Combination With Chemotherapy
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Gemcitabine
Related studies linked through entity extraction aliases.
Study of Intratumoral REOLYSIN® in Combination With Gemcitabine and Cisplatin as Neoadjuvant Therapy in Muscle-invasive Transitional Cell Carcinoma of the Bladder
- Status
- WITHDRAWN
- Phase
- PHASE1
Perioperative Therapy for Resectable and Borderline-Resectable Pancreatic Adenocarcinoma With Molecular Correlates
- Status
- COMPLETED
- Phase
- PHASE2
STUDY 15 - Comparing Gemcitabine/Carboplatin and Hydroxychloroquine Versus Carboplatin/Etoposide Therapy Alone in Small Cell Lung Cancer (SCLC)
- Status
- TERMINATED
- Phase
- PHASE2
A Study of PEGylated Recombinant Human Hyaluronidase in Combination With Nab-Paclitaxel Plus Gemcitabine Compared With Placebo Plus Nab-Paclitaxel and Gemcitabine in Participants With Hyaluronan-High Stage IV Previously Untreated Pancreatic Ductal Adenocarcinoma
- Status
- TERMINATED
- Phase
- PHASE3
A Study of the Safety and Efficacy of Atezolizumab Administered in Combination With Bevacizumab and/or Other Treatments in Participants With Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Ramucirumab (LY3009806) or Merestinib (LY2801653) in Advanced or Metastatic Biliary Tract Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Open-Label Safety and Tolerability Study of INCB057643 in Subjects With Advanced Malignancies
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Study To Establish Maximum Tolerated Dose (MTD) of Cyberknife in Patients With Un-Resectable Pancreas Cancer (TL002)
- Status
- TERMINATED
- Phase
- PHASE1
A Study of Pre-Operative Cyberknife in Patients With Potentially Resectable Pancreas Cancer
- Status
- UNKNOWN
- Phase
- EARLY_PHASE1
PEG-ASP, Etoposide and Gemcitabine for Natural Killer/T Lymphoma
- Status
- UNKNOWN
- Phase
- PHASE2
LOAd703 Oncolytic Virus Therapy for Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Belinostat Combined With Azacitidine/Gemcitabine/Busulfan/Melphalan With Autologous Stem-Cell Transplantation in Refractory or Relapsed Lymphoma
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
The Bladder Instillation Comparison Study
- Status
- COMPLETED
- Phase
- PHASE3
A Study of Erlotinib in Locally Advanced, Unresectable, or Metastatic Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Ibrutinib in Patients With Refractory/Relapsed Non-GCB Diffuse Large B-cell Lymphoma Non-candidates to ASCT
- Status
- COMPLETED
- Phase
- PHASE2
Decitabine Combined With Gemcitabine in First-line Treatment of AdvancedPancreatic Cancer
- Status
- UNKNOWN
- Phase
- NA
A Trial With Vinflunine in Patients With Metastatic Bladder Cancer and Impaired Renal Function
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Olaratumab (LY3012207) in Participants With Advanced Soft Tissue Sarcoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
D-CIK Combined With Chemotherapy for Non-Small Cell Lung Cancer(NSCLC)
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2